1. Home
  2. FT vs ACHV Comparison

FT vs ACHV Comparison

Compare FT & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Universal Trust

FT

Franklin Universal Trust

N/A

Current Price

$7.84

Market Cap

202.6M

Sector

Finance

ML Signal

N/A

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

N/A

Current Price

$4.23

Market Cap

239.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FT
ACHV
Founded
1988
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
202.6M
239.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FT
ACHV
Price
$7.84
$4.23
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$15.50
AVG Volume (30 Days)
63.0K
608.4K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
7.85%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.97
$1.84
52 Week High
$7.23
$5.78

Technical Indicators

Market Signals
Indicator
FT
ACHV
Relative Strength Index (RSI) 36.80 42.76
Support Level $7.79 $4.57
Resistance Level $7.91 $4.86
Average True Range (ATR) 0.10 0.27
MACD -0.02 -0.05
Stochastic Oscillator 12.50 0.61

Price Performance

Historical Comparison
FT
ACHV

About FT Franklin Universal Trust

Franklin Universal Trust is a closed-end management investment company focused on providing high current income while preserving capital. Its secondary objective is to achieve income growth through dividend increases and capital appreciation. The fund invests in two asset classes: high-yield bonds and utility stocks. It applies fundamental research to build a diversified high-yield bond portfolio and targets utility companies with attractive dividend yields and a history of increasing dividends.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Share on Social Networks: